Residual inflammation in the cerebrospinal fluid after short- and long-term natalizumab treatment in relapsing-remitting multiple sclerosis
Study Overview The study investigates the presence and implications of residual inflammation in the cerebrospinal fluid (CSF) of patients with […]
